정맥영양 관련 간기능 장애에서 조기 주기성 정맥영양법의 유용성
Early Management of Total Parenteral Nutrition Induced Hepatic Dysfunction with Cyclic Parenteral Nutrition
0
조회
0
다운로드
1
인용
0
참고문헌
초록
목 적: 담즙울체를 포함한 간기능 이상은 총정맥영양법을 시행받는 환자에게서 자주 나타나는 합병증 중 하나이며 이를 해소하기 위한 방법의 하나로서 주기성 정맥영양법이 있으나 소아에서는 이에 대한 연구가 미흡한 상태이다. 본 연구에서는 소아에서 총정맥영양법의 합병증으로 생긴 간기능 이상의 발생초기에 주기성 정맥영양법을 시행하여 그 유용성을 평가하고자 하였다.방 법: 연구대상은 미숙아를 제외한 유소아로 총정맥영양법에 의한 담즙울체 및 간효소치의 증가를 보이고 혈역학적, 대사적으로 안정되었으며 주기성 정맥영양법이 간기능 이상을 보이는 초기에 시도되었던 12례의 환아들이었다. 주기성 정맥영양법의 중단시간은 3개월 미만에서는 2시간 이하, 그 이상에서는 4시간으로 하였다. 환아들의 의무기록지를 후향적으로 검토하였고 진단명, 지속성과 주기성 정맥영양법의 시행기간과 방법, 대사성 혹은 감염성 합병증 유무, 병행된 경관영양유무 및 정맥영양법을 시행하기 전후의 혈청 총 빌리루빈과 간효소치의 변화를 비교하였다.
Abstract
Purpose: Liver function test abnormalities have been reported frequently in patients receiving total parenteral nutrition (TPN). In adults, it is known that liver complications decrease with the use of cyclic parenteral nutrition (CPN), especially if the shift to cycling was not too late. However, there are few studies about the effects of cycling on liver injury in children beyond the neonatal period. The aim of this study is to evaluate the effect of the early use of CPN on total parenteral nutrition induced hepatic dysfunction. Methods: Twelve sets of CPN in 11 children (2 months to 17 years) were included in this study. Data on underlying diseases, age, length of time on TPN, macronutrient intake, complications, and biochemical parameters were collected from clinical records. All children had received CPN in the early period of persistent transaminase elevation or cholestasis complicated by previous continuous PN. The duration of infusion off-time in CPN was 2 hours in patients less than 3 months of age and 4 hours in the older children. Results: All 12 cases showed elevated aminotransferase and 5 of them also showed cholestasis. Serum total bilirubin concentration was normalized in all 5 cases with median periods of 8 days (p<0.05) after initiation of CPN. ALT either decreased significantly or was normalized in all cases with median periods of 30 days (p<0.05) on CPN. The CPN was well tolerated without significant complication except for one case of hyperglycemia.Conclusion: The early use of cyclic parenteral nutrition had a beneficial effect in improving hepatic dysfunction complicated by TPN in children.
참고문헌 (41)
- Chung C, "Postoperative jaundice and total parenteral nutrition-associated hepatic dysfunction", 6, pp.1067~1084 (2002)
- Sandhu IS, "Total parenteral nutrition and cholestasis", 3, pp.489~508 (1999)
- MacFie J, "Cyclic parenteral nutrition", 13, pp.46~48 (1997)
- Bennett KM, "Cyclic parenteral nutrition", 5, pp.163~5 (1990)
- Hwang TL, "Early use of cyclic TPN prevents further deterioration of liver functions for the TPN patients with impaired liver function", 47, pp.1347~1350 (2000)
- Collier S, "Use of cyclic parenteral nutrition in infants less than 6 months of age", 9, pp.65~8 (1994)
- 정은희, "총정맥영양법에 의한 영유아의 담즙울체에 대한 주기성정맥영양법의 효과", 42, pp.1689~1695 (1999)
- Cavicchi M, "Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure", 132, pp.525~532 (2000)
- Anne M, "Davis, MS, Cycling and discontinuation", pp.220~222 (1997)
- Sondheimer JM, "Infection and cholestasis in neonates with intestinal resection and long-term parenteral nutrition", 27, pp.131~137 (1998)
- Angelico M, "Hepatobiliary complications associated with total parenteral nutrition", 14(2), pp.54~57 (2000)
- Postuma R, "Liver disease in infants receiving total parenteral nutrition", 63, pp.110~5 (1979)
- Ginn-Pease M, "TPN-associated hyperbilirubinemia:a common problem in newborn surgical patients", 20, pp.436~39 (1985)
- Craig RM, "Severe hepatocellular reaction resembling alcoholic hepatitis with cirrhosis after massive small bowel resection and prolonged total parenteral nutrition", 79, pp.131~7 (1980)
- Farrell MK, "Parenteral nutrition and hepatobiliary dysfunction", 13, pp.197~212 (1986)
- Aynsley-Green A, "Plasma hormone concentrations during enteral and parenteral nutrition in the human newborn", pp.108~12
- Fouin-Fortunet H, "Hepatic alterations during total parenteral nutrition in patients with inflammatory bowel disease:a possible consequence of lithocholate toxicity", 82, pp.932~7 (1982)
- Tomar BS, "Hepatobiliary abnormalities and parenteral nutrition", 67, pp.695~701 (2000)
- Vileisis RA, "Prospective controlled study of parenteral nutrition-associated cholestatic jaundice;Effect of protein intake", 96, pp.893~ (1980)
- Vinton NE, "Taurine concentrations in plasma,blood cells,and urine of children undergoing long-term total parenteral nutrition", 21, pp.399~403 (1987)
- Alan Buchman, "Total parenteral nutrition-associated liver disease", 26(5), pp.43~48 (2002)
- La Scala GC, "The addition of lipids increases the total parenteral nutrition-associated cholestasis in the rat", 3, pp.224~7 (1993)
- Colomb V, "Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children", 24, pp.345~350 (2000)
- Rief S, "Total parenteral nutrition-induced steatosis:Reversal by parenteral lipid infusion", 15, pp.102~4 (1991)
- Fell JM, "Manganese toxicity in children receiving long-term parenteral nutrition", 347, pp.1218~1221 (1996)
- 서정기, "총 정맥영양", pp.147~183 (2001), 고려의학
- Bowyer BA, "L-carnitine therapy in home parenteral nutrition patients with abnormal liver tests and low plasma carnitine concentrations", 94, pp.434~8 (1988)
- Bowyer BA, "Plasma carnitine levels in patients receiving home parenteral nutrition", 43, pp.85~91 (1986)
- Buchman AL, "Choline deficiency:a cause of hepatic steatosis during parenteral nutritionthat can be reversed with intravenous choline supplementation", 22, pp.1399~1403 (1995)
- Buchman AL, "Choline deficiency causes reversible hepatic abnormalities in patients receiving parenteral nutrition: proof of a human choline requirement: a placebo-controlled trial", 25, pp.260~268 (2001)
- Capron JP, "Metronidazole in prevention of cholestasis associated with total parenteral nutrition", pp.446~7
- Kubota A, "The effect of metronidazole on TPN-associated liver dysfunction in neonates", 25, pp.618~21 (1990)
- Lazaridis KN, "Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'", 35, pp.134~146 (2001)
- Rodrigues CM, "A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation", 101(12), pp.2790~2799 (1998)
- Teitelbaum DH, "Use of cholecystokinin to prevent the development of parenteral nutrition-associated cholestasis", 21, pp.100~103 (1997)
- Curran TJ, "The effect of cholecystokinin-octapeptide on the hepatobiliary dysfunction caused by total parenteral nutrition", 30, pp.242~246 (1995)
- Hyltander A, "Intravenous feeding kinetics and its effect on energy and nitrogen metabolism", 9, pp.51~ (1994)
- Hyltander A, "Metabolic rate and nitrogen balance in patients receiving bolus intermittent total parenteral nutrition infusion", 17, pp.158~64 (1993)
- Matuchansky C, "Cyclic(nocturnal)total parenteral nutrition in hospitalized adult patients with severe digestive diseases", 81, pp.433~7 (1981)
- Wood RJ, "Calciuretic effect of cyclic versus continuous total parenteral nutrition", 41, pp.614~9 (1985)
- Jannace PW, "Total parenteral nutrition-induced cyclic hypercapnia", 16, pp.727~8 (1988)
